Andy Itsara

Hematology
1959 NE Pacific St
Seattle, WA 98195

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications

Sudden death and asymptomatic arrhythmia in chronic lymphocytic leukemia patients treated with ibrutinib.

Sudden death and asymptomatic arrhythmia in chronic lymphocytic leukemia patients treated with ibrutinib.

Journal: Heart rhythm
Published: July 02, 2025

A Decade of Ibrutinib for CLL with and without TP53 Aberration: Final Report on an Investigator-Sponsored Phase 2 Study.

A Decade of Ibrutinib for CLL with and without TP53 Aberration: Final Report on an Investigator-Sponsored Phase 2 Study.

Journal: Blood
Published: June 06, 2025

A decade of ibrutinib for CLL with and without TP53 aberration: final report on an investigator-sponsored phase 2 study.

A decade of ibrutinib for CLL with and without TP53 aberration: final report on an investigator-sponsored phase 2 study.

Journal: Blood
Published: June 06, 2025

CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy.

CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 22, 2022

Actionable exomic incidental findings in 6503 participants: challenges of variant classification.

Actionable exomic incidental findings in 6503 participants: challenges of variant classification.

Journal: Genome research
Published: February 01, 2015

Resolving genomic disorder-associated breakpoints within segmental DNA duplications using massively parallel sequencing.

Resolving genomic disorder-associated breakpoints within segmental DNA duplications using massively parallel sequencing.

Journal: Nature protocols
Published: May 31, 2014

Resolving the breakpoints of the 17q21.31 microdeletion syndrome with next-generation sequencing.

Resolving the breakpoints of the 17q21.31 microdeletion syndrome with next-generation sequencing.

Journal: American journal of human genetics
Published: November 30, 2011
Showing 1-7 of 7

Last Updated: 09/26/2026